The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
All content for The Downstream Column Podcast is the property of Brandy Sargent and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
Continuous Biomanufacturing Implementation Now and in The Future
The Downstream Column Podcast
12 minutes 14 seconds
7 years ago
Continuous Biomanufacturing Implementation Now and in The Future
In this podcast, we interviewed Dr. Peter Levison, Senior Marketing Director – Downstream Processing, Pall Life Sciences about the evolution and benefits of continuous biomanufacturing, what implementation looks like today and what still needs to be realized for full industry adoption.
View show notes at downstreamcolumn.com/podcast/continuous-biomanufacturing-implementation-now-and-in-the-future/
The Downstream Column Podcast
The Downstream Column (DsC) is an online publication targeting members of the biologics industry. Our intent is to provide a community to share expertise and best practices as well as discuss topics of interest. The Downstream Column covers areas important to the research, discovery, development, and manufacture of biologic therapeutics. Key industry coverage areas include: purification, formulation, fill/finish, and QA/QC for cell and gene therapies, vaccines, biologics, and emerging therapeutic modalities.
